These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride. Fukuda T, Numao T, Akutsu I, Toda M, Motojima S, Makino S. Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299 [Abstract] [Full Text] [Related]
16. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals. Bendall LJ, Makrynikola V, Hutchinson A, Bianchi AC, Bradstock KF, Gottlieb DJ. Leukemia; 1998 Sep; 12(9):1375-82. PubMed ID: 9737685 [Abstract] [Full Text] [Related]
17. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. Tamura N, Agrawal DK, Townley RG. J Immunol; 1988 Dec 15; 141(12):4291-7. PubMed ID: 2848892 [Abstract] [Full Text] [Related]
18. Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4. Abraham WM, Ahmed A, Sielczak MW, Narita M, Arrhenius T, Elices MJ. Am J Respir Crit Care Med; 1997 Sep 15; 156(3 Pt 1):696-703. PubMed ID: 9309981 [Abstract] [Full Text] [Related]
19. Interleukin-3 and Flt3-ligand induce adhesion of Baf3/Flt3 precursor B-lymphoid cells to fibronectin via activation of VLA-4 and VLA-5. Shibayama H, Anzai N, Ritchie A, Zhang S, Mantel C, Broxmeyer HE. Cell Immunol; 1998 Jul 10; 187(1):27-33. PubMed ID: 9682000 [Abstract] [Full Text] [Related]
20. Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. Shindo K, Koide K, Hirai Y, Sumitomo M, Fukumura M. Thorax; 1996 Feb 10; 51(2):155-8. PubMed ID: 8711647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]